Altamira Therapeutics Executives
Altamira Therapeutics employs about 10 people. The company is managed by 6 executives with a total tenure of roughly 24 years, averaging almost 4.0 years of service per executive, having 1.67 employees per reported executive. Analysis of Altamira Therapeutics' management performance can provide insight into the firm performance.
Altamira |
Altamira Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.5715) % which means that it has lost $0.5715 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6878) %, meaning that it created substantial loss on money invested by shareholders. Altamira Therapeutics' management efficiency ratios could be used to measure how well Altamira Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Altamira Therapeutics Workforce Comparison
Altamira Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 179. Altamira Therapeutics holds roughly 10.0 in number of employees claiming about 6% of equities under Health Care industry.
Altamira Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Altamira Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Altamira Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Altamira Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mollica Joseph A over three months ago Acquisition by Mollica Joseph A of 138 shares of Altamira Therapeutics subject to Rule 16b-3 | ||
Lokay Kevin G over three months ago Acquisition by Lokay Kevin G of 10000 shares of Altamira Therapeutics at 11.5 subject to Rule 16b-3 | ||
Carter Stephen over three months ago Disposition of 10000 shares by Carter Stephen of Altamira Therapeutics at 0.62 subject to Rule 16b-3 | ||
Mollica Joseph A over six months ago Acquisition by Mollica Joseph A of 198 shares of Altamira Therapeutics subject to Rule 16b-3 | ||
Schnittker Christopher P over six months ago Acquisition by Schnittker Christopher P of 18000 shares of Altamira Therapeutics at 5.15 subject to Rule 16b-3 | ||
Schnittker Christopher P over six months ago Acquisition by Schnittker Christopher P of 10000 shares of Altamira Therapeutics at 11.5 subject to Rule 16b-3 |
Altamira Therapeutics Notable Stakeholders
An Altamira Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Altamira Therapeutics often face trade-offs trying to please all of them. Altamira Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Altamira Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Meyer | President, Founder | Profile | |
| Covadonga Paeda | Chief Officer | Profile | |
| Covadonga Paneda | Chief Officer | Profile | |
| Jean Lechance | Unit Bus | Profile | |
| Samuel MD | Chief Officer | Profile | |
| Marcel CPA | Chief Officer | Profile |
Altamira Therapeutics Workforce Analysis
Traditionally, organizations such as Altamira Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Altamira Therapeutics within its industry.Altamira Therapeutics Manpower Efficiency
Return on Altamira Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 386.9K | |
| Net Loss Per Executive | 644.9K | |
| Working Capital Per Employee | 33.4K | |
| Working Capital Per Executive | 55.7K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Altamira Stock
If you are still planning to invest in Altamira Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Altamira Therapeutics' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |